Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Y Cheung

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Diabetes Science and Technology|February 21, 2015
Reimbursement programs and health technology assessment for diabetes devices and supplies: a Canadian perspectiveRichard Y Cheung, Vanessa Mui
Journal of Diabetes Science and Technology|April 10, 2013
An overview of Canadian and U.S. approaches to drug regulation and responses to postmarket adverse drug reactionsRichard Y Cheung, Sarah H Goodwin
Anti-Cancer Drugs|March 5, 2005
In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulationsRichard Y Cheung, Andrew M Rauth, Xiao Yu Wu
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2004
A new approach to the in vivo and in vitro investigation of drug release from locoregionally delivered microspheresRichard Y Cheung, Robert Kuba, Andrew M Rauth, et al.
Biomaterials|April 9, 2005
Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin CRichard Y Cheung, Yuming Ying, Andrew M Rauth, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 7, 2005
In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicinRichard Y Cheung, Andrew M Rauth, Patrick T Ronaldson, et al.
Breast Cancer Research and Treatment|February 18, 2009
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cellsAdam J Shuhendler, Richard Y Cheung, Janet Manias, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Diabetes Science and Technology|February 21, 2015
Reimbursement programs and health technology assessment for diabetes devices and supplies: a Canadian perspectiveRichard Y Cheung, Vanessa Mui
Journal of Diabetes Science and Technology|April 10, 2013
An overview of Canadian and U.S. approaches to drug regulation and responses to postmarket adverse drug reactionsRichard Y Cheung, Sarah H Goodwin
Anti-Cancer Drugs|March 5, 2005
In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulationsRichard Y Cheung, Andrew M Rauth, Xiao Yu Wu
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2004
A new approach to the in vivo and in vitro investigation of drug release from locoregionally delivered microspheresRichard Y Cheung, Robert Kuba, Andrew M Rauth, et al.
Biomaterials|April 9, 2005
Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin CRichard Y Cheung, Yuming Ying, Andrew M Rauth, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 7, 2005
In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicinRichard Y Cheung, Andrew M Rauth, Patrick T Ronaldson, et al.
Breast Cancer Research and Treatment|February 18, 2009
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cellsAdam J Shuhendler, Richard Y Cheung, Janet Manias, et al.
Pageof 1